TranSYS results are expected to translate clinical and omics data into models to support and accelerate the clinical development of new drugs and therapies using stratification of patients and Precision Medicine approaches. Efficient and proven methods and strategies will be implemented into well-documented computer programs and workflow systems, with software-supported interfaces, and translated into Standard Operating Procedures and (Policy) Guidelines. Exploitation activities are overviewed by the TranSYS Valorization Board.